J.H. Whitney Equity Partners VII, LLC holds a concentrated book of 1 stock worth $231.9M as of Q2 2026 (disclosed Aug 3, 2026, a ~34-day 13F lag). This quarter they trimmed Aveanna Healthcare Holdings. Their largest long position is Aveanna Healthcare Holdings at 100% of the equity book.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices (an exit at the prior quarter-end), no cost basis
No buys this quarter.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Aveanna Healthcare Holdings Inc. COM | $231.9M | 27.06M | 100.0% | ▼−25% Reduced · −9.2M sh |
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1567459/holdings"
Use Arkolith to show J.H. Whitney Equity Partners VII, LLC's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Aug 3, 2026 | 1 | $231.9M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | May 7, 2026 | 1 | $233.4M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 11, 2026 | 1 | $296.1M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 6, 2025 | 1 | $406.6M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 4, 2025 | 1 | $240.2M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | Apr 30, 2025 | 1 | $263.0M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Jan 21, 2025 | 1 | $222.4M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 4, 2024 | 1 | $253.0M | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Jul 19, 2024 | 1 | $134.3M | 13F-HR |
| Q1 2024 | Mar 31, 2024 | Apr 23, 2024 | 1 | $121.2M | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 7, 2024 | 1 | $130.4M | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Oct 20, 2023 | 1 | $57.9M | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Jul 18, 2023 | 1 | $82.2M | 13F-HR |
| Q1 2023 | Mar 31, 2023 | Jun 12, 2023 | 1 | $50.6M | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 7, 2023 | 1 | $38.0M | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Nov 2, 2022 | 1 | $73.0M | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Aug 4, 2022 | 1 | $110.0M | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 9, 2022 | 1 | $165.9M | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Feb 14, 2022 | 1 | $360.1M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.